Thrombosis 230327052944 830adaab
Thrombosis 230327052944 830adaab
Thrombosis 230327052944 830adaab
waleed
Group .08
6 year
THROMBOSIS
Thrombus – a blood clot.
Thrombosis – a pathological process whereby there is
formation of a blood clot in uninjured vasculature or
after relatively minor injury.
There are three main predisposing factors for
thrombus formation (Virchow’s triad):
* Damage to the endothelial lining of a blood vessel.
* Relative stasis or turbulence of blood flow.
* Increased coagulability of blood.
These predisposing factors are associated with
particular conditions or life styles
THROMBOSIS
Virchow triad
1-ENDOTHELIAL DAMAGE
IN HEART AND ARTERIAL CIRCULATION
a. Endocardial injury (example MI, Valvulitis)
b. Over ulcerated plaques in the atherosclerotic
arteries
c. Hemodynamic stress: like hypertension
d. Turbulent flow over the scarred valves
e. At the sites of the traumatic or inflammatory
vascular injury
f. Hypercholesterolemia
g. Radiation or products absorbed from the Cigar
smoke.
1-ENDOTHELIAL DAMAGE (Cont--)
Chemical injury.
Drugs.
Immune reactions.
Endotoxin.
2-STASIS/TURBULENCE (contd…):
Turbulence contributes to arterial & cardiac thrombosis
by causing endothelial injury.
Stasis is major factor in development of venous thrombi.
Both stasis & turbulence
◦ Disrupt laminar flow & bring platelets into
contact with the endothelium.
◦ Prevents dilution of clotting factors inhibitors
◦ Slow down the inflow of clotting factor
inhibitors
◦ Promotes endothelial cell activation.
2-STASIS/TURBULENCE
HYPERCOAGULABILITY:
Alteration of coagulation pathways that
predispose to thrombosis.
Hypercoagulability can be
Primary (genetic)
Secondary (acquired).
3-INCREASED COAGULABILITY (contd…):
Primary (genetic).
Mutation in factor V (proaccelerin) gene (Leiden mutation) &
Mutation in factor II gene (prothrombin gene) .
Factor V becomes resistant to protein c inactivation
Prothrombin (II) levels elevated
Mutation in methyltetrahydrofolate gene
RARE CAUSE
Less commonly inherited deficiencies of anti-thrombin-III, protein C or
protein S.
Congenitally elevated levels of homocysteine.
3-INCREASED COAGULABILITY (contd…):
Secondary (acquired)
HIGH RISK FACTORS
Stasis or vascular injury may be most important
Immobilization
Cancer
MI and atrial firillation
Tissue damage(surgery, fracture, burns)
LOWER RISK FACTORS
Cardiomyopathy
Nephrotic syndrome
Oral contraceptive
Hyper estrogenic state of pregnancy
Advancing age leading to increased platelet aggregation.
Smoking & obesity
Mural thrombi
Non-infected,Verrucous-endocarditis-(Libman-Sacks
endocarditis) due to elevated levels of circulating immune
complexes
Thrombus - Morphology
Arterial Venous
Almost always arise Deep veins (popleteal
from heart Femoral Iliac),
Grow in retrograde Antigrade (towards
fashion (direction of heart- direction of
flow) flow)
Forms at site of
Endothelial injury(AS), At site of stasis (lower
turbulence (aneurysms) extremities)
Pale/ white
Lines of Zahn Red / dark
Firmly adherent to No lines of Zahn
vessel wall Loosely attached
(easily embolize)
From emboli Cause Emboli cause
infarctions (lower Pulmonary embolism (
extremities – 75%, Brain silent in 50% of pts.)
(10%), Kidney, spleen)
Thrombus - Morphology
Venous Post mortem clot
Loosely attached Not attached
(easily embolize)
Red/ dark Dark red dependant
portion & yellow
chicken fat
supernatant
Thrombi cause obstruction of arteries & veins.
They are possible sources of emboli.
Venus thrombosis:
Mostly occurs in superficial & deep veins of legs.
Superficial venous thrombi.
Usually in saphenous system esp. in varicosities.
Local congestion, swelling, pain & tenderness along the
course of involved vein.
Rarely embolize.
Predispose the overlying skin to infections.
Clinical correlations (contd…):
Venous thrombosis (contd):
Deep venous thrombosis.
In larger leg veins at or above the knee joint
(popliteal, femoral & iliac veins)
They embolize & so are clinically serious.
May cause local pain & edema.
Collateral bypass channels.
Asymptomatic in 50% of cases.
Recognized only after they have embolized.
Clinical correlations (contd…):
Cardiac & arterial thrombosis:
Myocardium infarction
Dyskinetic contraction of the myocardium & damage
to the adjacent endothelium leading to mural
thrombi.
Rheumatic heart disease.
Mitral valve stenosis.
Left atrial dilatation.
Atrial fibrillation
Clinical correlations (contd…):
Atherosclerosis.
It is a prime initiator of thrombosis related
to loss of endothelial integrity & abnormal
vascular flow.
Complication of cardiac & aortic mural thrombi
Peripheral embolization
Common sites: Brain, kidneys & spleen
Propagation
Embolization
Dissolution
Medical management
Anticoagulant medicines like…
Heparin given intravenously and
Warfarin is given via mouth.
Thrombolytic therapy.
NSAID ibuprofen.
Physiotherapy.
It is paramount that thrombosis
collaborative care programmes
include the physiotherapist to
encourage specific ambulatory
regimes. For each patient, an initial
assessment begins with discussion
and observation of the patient’s
actual and achievable ambulation
capacity:
Independent walking activity (achieved by
patient).
Active walking exercises (ten times hourly).
Walking activities will significantly help to
reduce deficits in venous blood flow by
activating skeletal calf muscle pumps.
It is also important to make optimum use of
the respiratory system (respiratory pumps),
to encourage specified breathing
mechanisms and to initiate collaborative
skeletal and respiratory pump exercises